Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by BearDownAZ


V.BTI.H

BiOasis presenting at Brains for Brain 2017 meeting

Brains for Brain International Workshop is coming up March 29th to April...

March 28, 2017

T.RVX

RE:RE:RE:MOA apabetalone (rvx-208)

BigDolphin asked "Why doesn't it reflect in our share price?"...

March 24, 2017

T.RVX

RE:MOA apabetalone (rvx-208)

Thanks for the reminder Toniv. A nice blast from the past to remind us of how...

March 24, 2017

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:MY TAKE.......

JD, You make good points. However, I am not suggesting that they do a non...

March 22, 2017

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:RE:RE:MY TAKE.......

JD wrote: "If all of that work could have been done with OPM, then why...

March 21, 2017

V.BTI.H

RE:RE:RE:RE:RE:RE:RE:MY TAKE.......

Although the Mtfp peptide is based upon human sequence, that doesn't...

March 21, 2017

T.RVX

RE:futility assessment

The trial is currently designed to proceed until 250 adjucated MACE events...

March 21, 2017

V.BTI.H

RE:RE:RE:RE:RE:and there you have it.

Yes I do. BDAZ

March 21, 2017

V.BTI.H

RE:RE:RE:and there you have it.

Thanks. I found it on Stockwatch. I'm not surprised about the NR not...

March 21, 2017

V.BTI.H

RE:and there you have it.

Anyone have a link to this NR? I can't find it on SEDAR, the Bioasis...

March 21, 2017

T.RVX

RE:RE:HDL RELEVANCE IN NEW DRUG RESEARCH

Ron, It's all a matter of perception. If one classifies RVX-208 only as...

March 20, 2017

ESPR

Esperion Announces FDA Confirmation For LDL-Lowering Path

Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval...

March 20, 2017

T.RVX

RE:RE:RVX simply too late

Great post Toniv. Just a one comment and one correction. Comment: Although...

March 18, 2017

T.RVX

RE:RE:RE:RE:RE:REPATHA

Well this is interesting. The ~20% RRR in 3-point MACE for Repatha in FOURIER...

March 17, 2017

T.RVX

RE:RE:RE:RE:REPATHA

As you pointed out, BETonMACE patient population is different (diabetic, low...

March 17, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:BEAR-Re News Release

The RVX team may need to revise that NNT, Cost/event slide bases on today'...

March 17, 2017

ESPR

Fourier/Repatha study

Great news from Amgen for Repatha showing a profound reduction of MACE with...

March 17, 2017

T.RVX

RE:REPATHA

Great news from Amgen for Repatha showing a profound reduction of MACE with...

March 17, 2017

T.RVX

RE:RE:RE:RE:RE:RE:RE:BEAR-Re News Release

Toniv, There is no official target RRR for success. BETonMACE is powered for...

March 16, 2017

T.RVX

RE:RE:RE:RE:RE:BEAR-Re News Release

Toniv, Why is Lipitor included? Atorvastatin (Lipitor) was included based...

March 15, 2017